ArticleBMC primary care2025
Polypharmacy among adults receiving outpatient care at Kitgum General Hospital, Northern Uganda.
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPolypharmacy is a major safety concern, associated with adverse outcomes, higher health services utilization, and healthcare costs. However, there is limited data on polypharmacy in the outpatient settings in semi-urban primary care settings. We assessed the prevalence and factors associated with polypharmacy among adults receiving outpatient care at Kitgum General Hospital, Uganda.
methodsWe conducted a facility-based, cross-sectional study among adults receiving outpatient care at Kitgum General Hospital between October and December 2023. Polypharmacy was defined as the concurrent use of five or more medicines. Data was collected using a structured tool. A multivariable logistic regression analysis was performed to assess the factors associated with polypharmacy.
resultsA total of 422 participants, with a mean age of 43.0 ± 18.3 years were enrolled. More than a third of the participants (35.3%, n = 149) had chronic medical conditions. Overall, 43.4% (n = 183) (95% CI: 38.7-48.2) of the participants had polypharmacy. The majority were on antibiotics (91.8%, n = 168) and analgesics (77.6%, n = 142). In total, 145 (34.4%) reported use of over-the-counter drugs and 60 (14.2) used herbal medicines. Having a chronic illness (Adjusted Odds Ratio (aOR): 5.93, 95% CI: 3.10-11.34, p < 0.001), and use of over-the-counter drugs (aOR: 16.7; 95% CI: 8.87-31.42, p = 0.009) were associated with higher odds of polypharmacy. Herbal medicine use was associated with 64% lower odds of polypharmacy (aOR: 0.36; 95% CI: 0.17-0.77, p < 0.001).
conclusionPolypharmacy was observed in almost 2 in every 5 adults receiving outpatient care in Kitgum General Hospital. Chronic illness and use of over the counter medicines increased the odds of polypharmacy among adult outpatients. Priority should be put in place to mitigate polypharmacy among outpatients in Northern Uganda and similar low resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.